| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1792 |
| Trial ID | NCT03298828 |
| Disease | Burkitt Lymphoma | Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | CD19 CAR and PD-1 Knockout Engineered T Cells for CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma |
| Year | 2017 |
| Country | China |
| Company sponsor | Third Military Medical University |
| Other ID(s) | TMMU-CAR-001 |
| Cohort 1 | |||||||||||||
|
|||||||||||||